ResMed
Preço: 194.78Empresa e modelo de negócios
ResMed is a healthcare company specializing in cloud-connected devices and software solutions for people with sleep apnea and chronic obstructive pulmonary disease (COPD). Its core products include continuous positive airway pressure (CPAP) devices, masks, and cloud-based software for patient management. The company operates primarily in the sleep and respiratory care segments, with major revenue sources stemming from device sales, software subscriptions, and related accessories.
Perfil de investimento
The investment profile of ResMed is more aligned with balanced investors, given its moderate growth potential and dividend yield. The company offers a steady revenue stream while also providing some income through dividends. However, the elevated risk factors suggest caution for those seeking aggressive growth.
Métricas fundamentais (experimental)
- EPS (TTM) — lucro por ação dos últimos 12 meses, $
- 10.38 OK
- Receita QoQ — crescimento da receita trimestre contra trimestre
- 0.6% ≈
- Surpresa de EPS
- 2.5% em linha
- Volatilidade 20d
- 2.1% estável
- Dividend yield
- 1.3% moderado última data ex-dividendo: 2026-05-14
Acompanhar no portfólio
Gráfico de preço
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-06-03 02:51 | Manter | Vender | Weak momentum and high risk overshadow potential upside. |
| 2026-05-24 02:49 | Vender | Manter | Weak momentum and mixed fundamentals suggest caution. |
| 2026-05-08 15:18 | — | Vender | Weak momentum and high risk overshadow potential upside. |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-05-01 12:52 | Robert W. Baird | Preço-alvo reduzido | 254 → 225 | 203.87 |
| 2026-04-27 10:21 | KeyBanc | Preço-alvo reduzido | 302 → 290 | 219.85 |
| 2026-04-13 14:44 | Evercore ISI | Preço-alvo reduzido | 300 → 255 | 228.33 |
Nada ainda